In another study, it was found that T cells of SLE patients show robust activation of the mechanistic target of rapamycin (mTOR), which is a sensor of the change in membrane potential of the mitochondria and therefore a key player in T-cell signaling that is defective in SLE. This evidence concerns the gene MTOR and systemic lupus erythematosus.